Mito.newsMito.news
← All articlesEditorial brief · abstract-levelScore 59/100Confidence medium
biorxiv2026-08-13redox biologymetabolismcardiovascularcomputational

2-Hydroxyglutarate Redirects Fatty Acid Partitioning to Mitigate Lipotoxic Stress and Preserve Metabolic Fuel

Scientific focus: redox biology, metabolism, cardiovascular, computational. Core claim (from abstract): Here we show that 2HG redistributes the partitioning of fatty acids into triglyceride storage and away from membrane phospholipid synthesis, mitochondrial oxidation, and lipotoxic intermediates. Dysfunction linkage: injury / ischemia; systemic metabolic stress. Moderate priority: useful for specialists in the listed topics.

Mito.news · at a glance

Signal profile (abstract-level)

redox biology · metabolism · cardiovascular · computational

Score 59/100BIORXIVmedium confidenceredox biology
59
Importance
50
Mito signal
53
Dysfunction
75
Evidence
30
Translational

Editorial signal profile from the abstract (importance score, mito keywords, dysfunction tags, evidence density, translational cues). Not a figure reproduced from the preprint PDF.

Verdict. Here we show that 2HG redistributes the partitioning of fatty acids into triglyceride storage and away from membrane phospholipid synthesis, mitochondrial oxidation, and lipotoxic intermediates. It intersects mitochondrial stress/dysfunction themes (injury / ischemia; systemic metabolic stress).

What the authors report

The role of 2-hydroxyglutarate in lipid metabolism is currently unknown. In primary human cardiac and vascular cells, both enantiomers, D2HG and L2HG, expanded triglyceride stores and lipid droplets while selectively depleting phosphatidylethanolamine, with L2HG acting more potently than D2HG despite lower intracellular accumulation.

Key results stated in the abstract include the following. Here we show that 2HG redistributes the partitioning of fatty acids into triglyceride storage and away from membrane phospholipid synthesis, mitochondrial oxidation, and lipotoxic intermediates. Mechanistically, L2HG increases DGAT-dependent triglyceride synthesis, slows triglyceride turnover, and constrains the ethanolamine branch of the Kennedy pathway. Thus, 2HG expands metabolic flexibility from whether fatty acids are used as fuel to how that fuel is allocated among storage, membrane synthesis, and oxidation.

Why it matters for mitochondrial biology

Within mitochondrial research, this work maps primarily to redox biology, metabolism, cardiovascular, computational. It is relevant to mitochondrial dysfunction discourse because the abstract invokes injury / ischemia, systemic metabolic stress. That does not by itself establish a validated disease mechanism; it indicates thematic proximity. Server: biorxiv. Posted 2026-08-13. Synthesis confidence is bounded by abstract completeness.

Study design (abstract-level)

This response limits fatty acid oxidation, long-chain acylcarnitine accumulation, and lipid peroxidation independently of pseudohypoxic transcription or canonical lipid storage regulators, while also remodeling the phosphoproteome and redox proteome. L2HG accumulation induces hypertriglyceridemia in mice, redistributes the acyl chain composition of cardiac triglycerides, and limits ischemia-induced acylcarnitine accumulation in the heart, mirroring a positive association between circulating 2HG and triglycerides in humans.

Principal findings

  1. Here we show that 2HG redistributes the partitioning of fatty acids into triglyceride storage and away from membrane phospholipid synthesis, mitochondrial oxidation, and lipotoxic intermediates.
  2. Mechanistically, L2HG increases DGAT-dependent triglyceride synthesis, slows triglyceride turnover, and constrains the ethanolamine branch of the Kennedy pathway.
  3. Thus, 2HG expands metabolic flexibility from whether fatty acids are used as fuel to how that fuel is allocated among storage, membrane synthesis, and oxidation.

Limitations of this brief

  • This Mitos brief is an abstract-level synthesis of a preprint; it is not peer review and not a substitute for reading the full paper.
  • Preprint status: findings may change with revision or journal review.
  • Effect sizes, n numbers, statistics, and full experimental controls are typically incomplete at abstract resolution.
  • Comparator/control language is weak or absent in the abstract, limiting causal inference from this brief alone.
  • Primary source: biorxiv DOI 10.64898/2026.08.12.744465 (posted 2026-08-13).

Open scientific questions

  • Which specific experimental panels in the full paper establish the strongest causal claim, and how robust are the controls?
  • How do these findings sit relative to prior literature on the same pathway—replication, contradiction, or incremental extension?

Bottom line

For mitochondrial biologists focused on redox biology, metabolism, cardiovascular, this preprint is worth full-text review if the topic matches your program. Abstract-level takeaway: Here we show that 2HG redistributes the partitioning of fatty acids into triglyceride storage and away from membrane phospholipid synthesis, mitochondrial oxidation, and lipotoxic intermediates. Confirm methods, effect sizes, and controls in the full PDF before citing the result as established.

Bibliographic record

FieldValue
Title2-Hydroxyglutarate Redirects Fatty Acid Partitioning to Mitigate Lipotoxic Stress and Preserve Metabolic Fuel
DOI10.64898/2026.08.12.744465
Serverbiorxiv
Posted2026-08-13
Topicsredox biology, metabolism, cardiovascular, computational
Mitos score59/100
Confidencemedium
HTMLhttps://www.biorxiv.org/content/10.64898/2026.08.12.744465
PDFhttps://www.biorxiv.org/content/10.64898/2026.08.12.744465.full.pdf

Abstract-based editorial synthesis by Mitos. Not peer review.

Test bot purchase (MetaMask)

Free HTML is above. To pay for the same content as JSON (bot path), open the purchase tester:

Buy JSON with MetaMask ($0.005)

Bot URL: /api/v1/papers/10-64898-2026-08-12-744465

Source preprint

2-Hydroxyglutarate Redirects Fatty Acid Partitioning to Mitigate Lipotoxic Stress and Preserve Metabolic Fuel

10.64898/2026.08.12.744465

Vigder N, Chandra A, Shrimali N, Tumanov S, Elgart V, He H, Mulhern R, Chakrabarty RP, Chandel NS, Cordwell SJ, Gygi S, Paulo JA, Loscalzo J.

Related briefs